Deletion of Vaccinia Virus A40R Gene Improves the Immunogenicity of the HIV-1 Vaccine Candidate MVA-B
出版年份 2020 全文链接
标题
Deletion of Vaccinia Virus A40R Gene Improves the Immunogenicity of the HIV-1 Vaccine Candidate MVA-B
作者
关键词
-
出版物
Vaccines
Volume 8, Issue 1, Pages 70
出版商
MDPI AG
发表日期
2020-02-07
DOI
10.3390/vaccines8010070
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins
- (2018) Adrián Lázaro-Frías et al. JOURNAL OF VIROLOGY
- Advances in HIV-1 Vaccine Development
- (2018) Yong Gao et al. Viruses-Basel
- Modulating Vaccinia Virus Immunomodulators to Improve Immunological Memory
- (2018) Jonas Albarnaz et al. Viruses-Basel
- Distinct susceptibility of HIV vaccine vector-induced CD4 T cells to HIV infection
- (2018) Sarah Auclair et al. PLoS Pathogens
- Potent HIV-1-Specific CD8 T Cell Responses Induced in Mice after Priming with a Multiepitopic DNA-TMEP and Boosting with the HIV Vaccine MVA-B
- (2018) Beatriz Perdiguero et al. Viruses-Basel
- Removal of the C6 Vaccinia Virus Interferon-β Inhibitor in the Hepatitis C Vaccine Candidate MVA-HCV Elicited in Mice High Immunogenicity in Spite of Reduced Host Gene Expression
- (2018) María Q. Marín et al. Viruses-Basel
- Priming with a Potent HIV-1 DNA Vaccine Frames the Quality of Immune Responses prior to a Poxvirus and Protein Boost
- (2018) Benedikt Asbach et al. JOURNAL OF VIROLOGY
- A Vaccine Based on a Modified Vaccinia Virus Ankara Vector Expressing Zika Virus Structural Proteins Controls Zika Virus Replication in Mice
- (2018) Patricia Pérez et al. Scientific Reports
- Distinct Roles of Vaccinia Virus NF-κB Inhibitor Proteins A52, B15, and K7 in the Immune Response
- (2017) Mauro Di Pilato et al. JOURNAL OF VIROLOGY
- Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization
- (2017) Alberto C. Guardo et al. PLoS One
- Immune Modulation of NYVAC-Based HIV Vaccines by Combined Deletion of Viral Genes that Act on Several Signalling Pathways
- (2017) Carmen Gómez et al. Viruses-Basel
- Monocytes Phenotype and Cytokine Production in Human Immunodeficiency Virus-1 Infected Patients Receiving a Modified Vaccinia Ankara-Based HIV-1 Vaccine: Relationship to CD300 Molecules Expression
- (2017) Joana Vitallé et al. Frontiers in Immunology
- Virological and immunological outcome of treatment interruption in HIV-1-infected subjects vaccinated with MVA-B
- (2017) Miriam Rosás-Umbert et al. PLoS One
- Balance between activation and regulation of HIV-specific CD8+ T-cell response after modified vaccinia Ankara B therapeutic vaccination
- (2016) Norma Rallón et al. AIDS
- C-type lectins: their network and roles in pathogen recognition and immunity
- (2016) Sabine Mayer et al. HISTOCHEMISTRY AND CELL BIOLOGY
- Deletion of A44L, A46R and C12L Vaccinia Virus Genes from the MVA Genome Improved the Vector Immunogenicity by Modifying the Innate Immune Response Generating Enhanced and Optimized Specific T-Cell Responses
- (2016) María Holgado et al. Viruses-Basel
- Safety and immunogenicity of a modified vaccinia Ankara-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1
- (2015) B. Mothe et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Innate immunity against HIV-1 infection
- (2015) Marcus Altfeld et al. NATURE IMMUNOLOGY
- A Phase I Randomized Therapeutic MVA-B Vaccination Improves the Magnitude and Quality of the T Cell Immune Responses in HIV-1-Infected Subjects on HAART
- (2015) Carmen Elena Gómez et al. PLoS One
- A Chimeric HIV-1 gp120 Fused with Vaccinia Virus 14K (A27) Protein as an HIV Immunogen
- (2015) Aneesh Vijayan et al. PLoS One
- NFκB activation by modified vaccinia virus as a novel strategy to enhance neutrophil migration and HIV-specific T-cell responses
- (2015) Mauro Di Pilato et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Attenuated poxvirus vectors MVA and NYVAC as promising vaccine cadidates against HIV/AIDS
- (2014) Mariano Esteban Human vaccines & immunotherapeutics
- Deletion of the Vaccinia Virus N2L Gene Encoding an Inhibitor of IRF3 Improves the Immunogenicity of Modified Vaccinia Virus Ankara Expressing HIV-1 Antigens
- (2014) J. Garcia-Arriaza et al. JOURNAL OF VIROLOGY
- A Novel Poxvirus-Based Vaccine, MVA-CHIKV, Is Highly Immunogenic and Protects Mice against Chikungunya Infection
- (2014) J. Garcia-Arriaza et al. JOURNAL OF VIROLOGY
- Vaccines that stimulate T cell immunity to HIV-1: the next step
- (2014) Andrew J McMichael et al. NATURE IMMUNOLOGY
- Early Skewed Distribution of Total and HIV-Specific CD8+ T-Cell Memory Phenotypes during Primary HIV Infection Is Related to Reduced Antiviral Activity and Faster Disease Progression
- (2014) Yanina Ghiglione et al. PLoS One
- Enhancing poxvirus vectors vaccine immunogenicity
- (2014) Juan García-Arriaza et al. Human Vaccines & Immunotherapeutics
- Innate Immunity and Vaccines
- (2013) Andrew Platt et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Clinical applications of attenuated MVA poxvirus strain
- (2013) Carmen Elena Gómez et al. Expert Review of Vaccines
- Vaccinia virus immune evasion: mechanisms, virulence and immunogenicity
- (2013) G. L. Smith et al. JOURNAL OF GENERAL VIROLOGY
- Harnessing CD4+ T cell responses in HIV vaccine development
- (2013) Hendrik Streeck et al. NATURE MEDICINE
- Improving Adaptive and Memory Immune Responses of an HIV/AIDS Vaccine Candidate MVA-B by Deletion of Vaccinia Virus Genes (C6L and K7R) Blocking Interferon Signaling Pathways
- (2013) Juan García-Arriaza et al. PLoS One
- Deletion of the Vaccinia Virus Gene A46R, Encoding for an Inhibitor of TLR Signalling, Is an Effective Approach to Enhance the Immunogenicity in Mice of the HIV/AIDS Vaccine Candidate NYVAC-C
- (2013) Beatriz Perdiguero et al. PLoS One
- Primary CD8+ T cells from elite suppressors effectively eliminate non-productively HIV-1 infected resting and activated CD4+ T cells
- (2013) Robert W Buckheit et al. Retrovirology
- Protective efficacy of Modified Vaccinia virus Ankara in preclinical studies
- (2013) Asisa Volz et al. VACCINE
- Clinical development of Modified Vaccinia virus Ankara vaccines
- (2013) Sarah C. Gilbert VACCINE
- Modified Vaccinia virus Ankara: Innate immune activation and induction of cellular signalling
- (2013) Philip J.R. Price et al. VACCINE
- Removal of Vaccinia Virus Genes That Block Interferon Type I and II Pathways Improves Adaptive and Memory Responses of the HIV/AIDS Vaccine Candidate NYVAC-C in Mice
- (2012) C. E. Gomez et al. JOURNAL OF VIROLOGY
- Deletion of Specific Immune-Modulatory Genes from Modified Vaccinia Virus Ankara-Based HIV Vaccines Engenders Improved Immunogenicity in Rhesus Macaques
- (2012) D. A. Garber et al. JOURNAL OF VIROLOGY
- Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
- (2012) Barton F. Haynes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improving the MVA Vaccine Potential by Deleting the Viral Gene Coding for the IL-18 Binding Protein
- (2012) Juliana Falivene et al. PLoS One
- Deletion of the Viral Anti-Apoptotic Gene F1L in the HIV/AIDS Vaccine Candidate MVA-C Enhances Immune Responses against HIV-1 Antigens
- (2012) Beatriz Perdiguero et al. PLoS One
- Vector replication and expression of HIV-1 antigens by the HIV/AIDS vaccine candidate MVA-B is not affected by HIV-1 protease inhibitors
- (2012) Juan García-Arriaza et al. VIRUS RESEARCH
- Poxvirus vectors as HIV/AIDS vaccines in humans
- (2012) Carmen Elena Gómez et al. Human Vaccines & Immunotherapeutics
- MVA and NYVAC as Vaccines against Emergent Infectious Diseases and Cancer
- (2011) Carmen E. Gomez et al. CURRENT GENE THERAPY
- The HIV/AIDS Vaccine Candidate MVA-B Administered as a Single Immunogen in Humans Triggers Robust, Polyfunctional, and Selective Effector Memory T Cell Responses to HIV-1 Antigens
- (2011) C. E. Gomez et al. JOURNAL OF VIROLOGY
- Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine
- (2011) Scott G. Hansen et al. NATURE
- Dendritic Cells Exposed to MVA-Based HIV-1 Vaccine Induce Highly Functional HIV-1-Specific CD8+ T Cell Responses in HIV-1-Infected Individuals
- (2011) Núria Climent et al. PLoS One
- A Candidate HIV/AIDS Vaccine (MVA-B) Lacking Vaccinia Virus Gene C6L Enhances Memory HIV-1-Specific T-Cell Responses
- (2011) Juan García-Arriaza et al. PLoS One
- Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02)
- (2011) Felipe García et al. VACCINE
- Induction of Immunity to Human Immunodeficiency Virus Type-1 by Vaccination
- (2010) M. Juliana McElrath et al. IMMUNITY
- Selective Induction of Host Genes by MVA-B, a Candidate Vaccine against HIV/AIDS
- (2010) S. Guerra et al. JOURNAL OF VIROLOGY
- Insertion of Vaccinia Virus C7L Host Range Gene into NYVAC-B Genome Potentiates Immune Responses against HIV-1 Antigens
- (2010) José Luis Nájera et al. PLoS One
- Immunogenic Profiling in Mice of a HIV/AIDS Vaccine Candidate (MVA-B) Expressing Four HIV-1 Antigens and Potentiation by Specific Gene Deletions
- (2010) Juan García-Arriaza et al. PLoS One
- Poxvirus vector-based HIV vaccines
- (2010) Giuseppe Pantaleo et al. Current Opinion in HIV and AIDS
- Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge
- (2009) Scott G Hansen et al. NATURE MEDICINE
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
- (2009) Supachai Rerks-Ngarm et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multimeric soluble CD40 ligand (sCD40L) efficiently enhances HIV specific cellular immune responses during DNA prime and boost with attenuated poxvirus vectors MVA and NYVAC expressing HIV antigens
- (2009) Carmen E. Gómez et al. VACCINE
- Innate Immune Sensing of Modified Vaccinia Virus Ankara (MVA) Is Mediated by TLR2-TLR6, MDA-5 and the NALP3 Inflammasome
- (2009) Julie Delaloye et al. PLoS Pathogens
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started